Testing effectiveness (Phase 2)Active Not RecruitingNCT06100276
What this trial is testing
Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
Who this might be right for
Amyotrophic Lateral Sclerosis
UniQure Biopharma B.V. 20